产品名称
Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H, clone 133-1H, Chemicon®, from mouse
biological source
mouse
conjugate
biotin conjugate
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
133-1H, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG2aκ
shipped in
wet ice
Quality Level
Application
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
Research Category
Infectious Diseases
Infectious Diseases
Detect Respiratory Syncytial Virus using this Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H validated for use in IF.
Immunofluorescence
Optimal working dilutions must be determined by the end user.
Optimal working dilutions must be determined by the end user.
Biochem/physiol Actions
Directed against the 47-49 kDa Fusion Protein of RSV. Antibody MAB858-1 recognizes both A and B RSV strains.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Respiratory Syncytial virus A2
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Biotin conjugated purified immunoglobulin. Liquid in 0.01M PBS, pH=7.1, 0.1% Sodium Azide with 15 mg/mL BSA as stabilizer
Preparation Note
Store at 2 to 8ºC for up to 12 months from date of receipt. Protect from light.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Megan Levy et al.
PLoS pathogens, 20(5), e1012198-e1012198 (2024-05-13)
Respiratory syncytial virus (RSV) is the most important viral agent of severe pediatric respiratory illness worldwide, but there is no approved pediatric vaccine. Here, we describe the development of the live-attenuated RSV vaccine candidate Min AL as well as engineered
N C Salisch et al.
NPJ vaccines, 4, 54-54 (2019-12-31)
Respiratory Syncytial Virus (RSV) can cause severe respiratory disease, yet a licensed vaccine is not available. We determined the immunogenicity of two homologous and one heterologous intramuscular prime-boost vaccination regimens using replication-incompetent adenoviral vectors of human serotype 26 and 35
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持